HWAM
CRMD icon

Hennion & Walsh Asset Management’s CorMedix CRMD Stock Holding History

Hennion & Walsh Asset Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.13M Buy
536,909
+98,280
+22% +$787K 0.12% 218
2026
Q2 		$3.44M Buy
438,629
+263,618
+151% +$2.08M 0.1% 258
2026
Q1 		$1.19M Buy
175,011
+37,117
+27% +$274K 0.04% 465
2025
Q4 		$1.6M Buy
+137,894
New +$1.52M 0.06% 402

Other funds holding CRMD

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Hennion & Walsh Asset Management's CRMD Position: Q3 2026 in Review

Hennion & Walsh Asset Management increased its CorMedix (CRMD) stake by 22% in Q3 2026, buying an estimated $787K and bringing the position to 536,909 shares worth $4.13M. The position accounts for 0.12% of the portfolio, ranked #218.

Hennion & Walsh Asset Management first reported a position in CRMD in Q4 2025 and has held it in 4 quarters since. 5 funds tracked by Wall St. Rank hold CRMD as of Q3 2026.

  • Hennion & Walsh Asset Management held 536,909 shares of CorMedix worth $4.13M as of Q3 2026.
  • Hennion & Walsh Asset Management bought 98,280 CorMedix shares in Q3 2026, an estimated $787K.
  • CorMedix made up 0.12% of Hennion & Walsh Asset Management's portfolio in Q3 2026, its #218 holding.
  • Hennion & Walsh Asset Management first reported a position in CorMedix in Q4 2025 and has held it in 4 quarters since.
  • 5 funds tracked by Wall St. Rank held CorMedix as of Q3 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q3 2026, filed 13 Oct 2026.